SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-012320
Filing Date
2022-12-09
Accepted
2022-12-09 16:30:40
Documents
1
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 form4-12092022_041206.html 4  
1 form4-12092022_041206.xml 4 7411
  Complete submission text file 0001415889-22-012320.txt   8846
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNITED THERAPEUTICS CORP 1040 SPRING STREET SILVER SPRING MD 20910
Business Address
BENKOWITZ MICHAEL (Reporting) CIK: 0001673232 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 221455186